Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bionano Laboratories Announced The Publication Of The First Framework Paper For The Clinical Adoption And Implementation Of The Optical Genome Mapping Workflow For Hematological Malignancy Applications

Author: Benzinga Newsdesk | January 03, 2024 09:51am

Framework was co-authored by an international consortium made up of 18 cancer researchers
Publication includes researchers' recommendations for laboratories planning to adopt optical genome mapping (OGM) on topics including assay development, clinical validation, implementation, algorithms for data interpretation, and strategies for efficient reporting
- Bionano Laboratories developed its laboratory developed test (LDT), marketed as OGM-Dx™ HemeOne, based on the process outlined in this publication

Posted In: BNGO